Samenvatting Hoofdstukken Molecular Biology of Cancer per OWG! - DOOR DEZE SAMENVATTING HEB IK DIT VAK NA 5X OPNIEUW MAKEN GEHAALD
17 views 1 purchase
Course
FA BA304 Oncologie
Institution
Universiteit Utrecht (UU)
Book
Molecular Biology of Cancer
Dit is een extensieve samenvatting voor FABA304 - Oncologie, waarop de focus gelegd is op het boek Molecular Biology of Cancer van Lauren Pecorino. Ik heb echt alle details van dit boek eruit gehaald - precies de dingen waar je overheen leest, omdat je denkt dat het niet belangrijk is voor het tent...
Samenvatting Hoofdstukken Molecular Biology of Cancer per OWG! - DOOR DEZE SAMENVATTING HEB IK DIT VAK NA 5X OPNIEUW MAKEN GEHAALD
Alle essentiele hoofdstukken van Pecorino samengevat!!
Cell cycle and important (proto-) oncogenes
All for this textbook (7)
Written for
Universiteit Utrecht (UU)
Farmacie
FA BA304 Oncologie
All documents for this subject (13)
Seller
Follow
instaglam
Reviews received
Content preview
Hoofdstuk 3 (wc 1)................................................................................................................. 5
§3.1 transcription factors and transcriptional regulation.....................................................5
§3.2 chromatin structure.....................................................................................................6
§3.3 epigenetic regulation of transcription..........................................................................7
Histone modification..................................................................................................... 7
DNA Methylation.......................................................................................................... 8
§3.4 evidence of a role for epigenetics in carcinogenesis..................................................8
Histone modication and cancer.................................................................................... 8
Methylation and cancer................................................................................................ 8
§3.5 long non-coding RNAs............................................................................................... 8
§3.6 microRNAs and regulation of mRNA expression....................................................... 9
§3.7 telomeren en telomerase............................................................................................9
§3.8 epigenomic and histonomic drugs............................................................................10
DNA methylation inhibitors......................................................................................... 10
Inhibitors of histone deacetylases.............................................................................. 10
§3.9 Non-coding RNAs for diagnosis............................................................................... 10
§3.10 telomerase inhibitors.............................................................................................. 10
Hoofdstuk 4 (owg 1)............................................................................................................. 10
§4.1 epidermal growth factor signaling: an important paradigm.......................................11
1. Growth factor binding..............................................................................................11
2. Dimerization............................................................................................................11
3. Autophosphorylation............................................................................................... 11
4. Translocatie van specifieke eiwitten naar het membraan.......................................12
5. RAS activation........................................................................................................ 12
6. Raf activation..........................................................................................................12
7. The MAPK kinase cascade.................................................................................... 12
8. Regulation of transcription factors..........................................................................13
The effect of cell signaling on cell behavior................................................................13
§4.2 oncogenes................................................................................................................14
Studies of retroviruses................................................................................................14
Growth factors............................................................................................................ 14
Growth factor receptors.............................................................................................. 14
Intracellular signal transducers...................................................................................15
Transcription factors................................................................................................... 15
Mechanisms of oncogenic mutations......................................................................... 15
§4.3 kinases as drug targets............................................................................................ 16
Anti-EGFR drugs........................................................................................................ 16
Strategies against Ras and Raf..................................................................................16
MEK inhibitors............................................................................................................ 16
Hoofdstuk 6 (owg 1)............................................................................................................. 17
§6.1 definitions of tumor supressor genes....................................................................... 17
§6.2 the retinoblastoma gene...........................................................................................17
§6.3 mutations in the RB pathway and cancer.................................................................17
, §6.4 the p53 pathway....................................................................................................... 18
Stucture of p53 protein............................................................................................... 18
Regulation of p53 protein by MDM2...........................................................................18
Upstream: molecular pathways van p53 activation.................................................... 19
Downstream: molecular mechanisms of p53 cellular effects......................................19
Inhibitie van de celcyclus......................................................................................19
Apoptosis..............................................................................................................20
DNA repair and angiogenesis and other emerging roles......................................21
Factors that decide downstream outcome: cell cycle arrest or apoptosis.................. 21
§6.5 mutations in the p53 pathway and cancer................................................................21
More complex than knudson’s two-hit hypothesis...................................................... 21
§6.6 interaction of DNA viral protein products with RB and p53...................................... 22
HPV causes cervical cancer.......................................................................................22
§6.7 targeting of the p53 pathway.................................................................................... 22
Strategies that aim to correct a p53 mutation.............................................................22
Hoofdstuk 2 (owg 2)............................................................................................................. 22
§2.1 gene structure.......................................................................................................... 22
§2.2 mutations..................................................................................................................23
§2.3 carcinogenic agents................................................................................................. 24
Radiation as a carcinogen..........................................................................................24
Ionizing radiation.................................................................................................. 24
Ultraviolet radiation...............................................................................................25
Chemical carcinogens.......................................................................................... 27
Infectious pathogens as carcinogens......................................................................... 28
Endogenous carcinogenic reactions.......................................................................... 28
§2.4 DNA repair and predispositions to cancer................................................................28
§2.5 conventional therapies: chemotherapy and radiation therapy..................................30
Chemotherapy............................................................................................................ 30
Alkylating agents and platinum-based drugs........................................................30
Antimetabolieten...................................................................................................31
Organische middelen............................................................................................31
Radiation therapy....................................................................................................... 31
Heterogeneous cell sensitivity and drug resistance................................................... 32
§2.6 strategies that target DNA repair pathways..............................................................32
Synthetic lethal strategies.......................................................................................... 32
Hoofdstuk 12 (owg 3)........................................................................................................... 33
§12.1 lymphocytes: B cells and T cells............................................................................ 33
§12.2 tumor suppresive roles of the immune system.......................................................34
The cancer immunity cycle......................................................................................... 34
§12.3 immune checkpoints...............................................................................................34
§12.4 cancer immunoediting and tumor promotion.......................................................... 35
§12.5 mechanisms of avoiding immune destruction........................................................ 35
§12.6 therapeutic antibodies............................................................................................ 36
§12.7 cancer vaccines......................................................................................................36
, Therapeutic vaccins................................................................................................... 36
Whole-cell vaccines..............................................................................................37
Peptide-based vaccines....................................................................................... 37
Dendritic cell vaccines.......................................................................................... 37
Vaccines for cancer prevention.................................................................................. 37
Hurdles to jump.......................................................................................................... 37
§12.8 immune checkpoint blockades............................................................................... 37
§12.9 adoptive T-cell transfer, modified T-cel receptors and chimeric antigen receptors.38
§12.10 oncolytic viruses and virotherapy......................................................................... 38
Hoofdstuk 5 (owg 4)............................................................................................................. 39
§5.1 cyclins and cyclin-dependent kinases (cdks)........................................................... 39
§5.2 mechanisms of cdk regulation..................................................................................40
§5.3 progression through the G1 checkpoint................................................................... 40
Structure of the RB protein......................................................................................... 40
Molecular mechanisms of the effects of RB............................................................... 41
§5.4 the G2 checkpoint.................................................................................................... 41
§5.5 the mitotic checkpoint...............................................................................................42
Aurora kinases........................................................................................................... 42
§5.6 the cell cycle and cancer.......................................................................................... 43
§5.7 cyclin-dependent kinase inhibitors........................................................................... 43
§5.8 other cell cycle kinase targets.................................................................................. 43
§5.9 inhibitors of the mitotic spindle................................................................................. 43
Hoofdstuk 7 (owg 4)............................................................................................................. 44
§7.1 molecular mechanisms of apoptosis........................................................................ 44
The extrinsic pathway: mediated by membrane death receptors...............................44
The intrinsic pathway: mediated by the mitochondria................................................ 45
Cross-talk between extrinsic and intrinsic pathways.................................................. 46
P53 and apoptosis......................................................................................................46
§7.2 apoptosis and cancer............................................................................................... 46
TRAIL receptors......................................................................................................... 47
Mutations that affect the extrinsic pathway.................................................................47
Mutations that affect regulators of the intrinsic pathway.............................................47
Alternative death pathways........................................................................................ 47
§7.3 Apoptosis and chemotherapy...................................................................................47
§7.4 apoptotic drugs.........................................................................................................48
Targeting TRAIL and its receptor................................................................................48
Regulation of the Bcl-2 family of proteins...................................................................48
Direct and indirect activation of caspases.................................................................. 48
Hoofdstuk 9 (hoorcollege)...................................................................................................48
9.1 How do tumors spread?............................................................................................. 49
9.2 The process of metastasis......................................................................................... 49
9.3 Invasion and epithelial-mesecnhymal transition.........................................................49
Induction of EMT........................................................................................................ 49
Tools of invasion......................................................................................................... 50
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through EFT, credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying this summary from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller instaglam. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy this summary for R122,15. You're not tied to anything after your purchase.
